Supernus Pharmaceuticals, Inc. (SUPN)
50.80
+0.59
(+1.18%)
USD |
NASDAQ |
Mar 17, 16:00
50.80
0.00 (0.00%)
After-Hours: 16:35
Supernus Pharmaceuticals Profit Margin (Quarterly) : -1.94% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | -2.24% |
| BridgeBio Pharma, Inc. | -126.2% |
| Corcept Therapeutics, Inc. | 11.83% |
| Catalyst Pharmaceuticals, Inc. | 34.53% |
| Cytokinetics, Inc. | -1.03K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.68% |
| Return on Assets | -2.65% |
| Return on Invested Capital | -3.55% |
| Gross Profit Margin (Quarterly) | 77.30% |
| Operating Margin (Quarterly) | 4.60% |
| Return on Net Operating Assets | -4.19% |